58Emerging
OMass Therapeutics
Series C· healthcare ai· Ranked #6 of 57 in healthcare ai
Score breakdown
Momentum72
Capital76
Traction10
Capital & traction
- Total raised
- $275M
- Last round
- Series C
- Round size
- $275M
- Round date
- 2026-10-16
- Valuation
- —
- Disclosed revenue
- —
Investors
Addition
Funding history
| Round | Date | Amount |
|---|---|---|
| Series C | 2026-10-16 | $275M |
Embed this score on your site
Copy the embed code
<a href="https://steek.live/companies/3436"><img src="https://api.steek.live/scoreboard/company/3436/badge.svg" alt="Steek Score" width="248" height="64" /></a>Competitors in healthcare ai
| Company | Raised | Score |
|---|---|---|
| Forus | $3.0B | 67 |
| Candid Health Candid Health builds automated healthcare revenue cycle management and medical billing software that helps medical groups, digital health companies, and billing teams submit claims, reduce denials, and accelerate insurance reimbursement workflows. | $120M | 64 |
| October 10 | $116M | 60 |
| Suki | $90M | 60 |
| Allara | $30M | 58 |
| Sava | $36M | 57 |
| HealthLeap | $38M | 56 |
| Scarlet | $50M | 55 |
| October 03 | $473M | 54 |
| Confido Health | $13M | 54 |
FAQs about OMass Therapeutics
What is OMass Therapeutics's Steek Score?
OMass Therapeutics has a Steek Score of 58 (Emerging) — a transparent 0–100 momentum index built from funding, traction and attention signals.
What sector is OMass Therapeutics in?
OMass Therapeutics operates in healthcare ai, where it ranks #6 of 57 by Steek Score.
How much funding has OMass Therapeutics raised?
OMass Therapeutics has raised $275M, most recently a Series C round (2026-10-16).
Who are OMass Therapeutics's competitors?
Top competitors include Forus, Candid Health, October 10.
Steek Score is a transparent momentum index computed from tracked public signals. Not investment advice.